Biographical Sketch
Joe G. Hollyfield, PhD, is Professor of Ophthalmology at the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University and is a member of the Graduate School Faculty, Kent State University, Kent, Ohio. He was Professor of Cell Biology, Neurobiology and Anatomy at Ohio State University, Columbus, Ohio, from 1996-2003. He received his PhD degree from the University of Texas at Austin and was a Postdoctoral Fellow at the Hubrecht Laboratory in Utrecht, The Netherlands. Dr. Hollyfield previously held faculty positions at Columbia University College of Physicians and Surgeons in New York City and at Baylor College of Medicine in Houston, Texas. He was Director of the Foundation Fighting Blindness Research Center in the Cullen Eye Institute at Baylor College of Medicine from 1978 until his move to Cleveland Clinic in 1995.
Dr. Hollyfield has published over 198 papers in the area of cell and developmental biology of the retina and retinal pigment epithelium in both normal and retinal degeneration tissues. He is currently Editor-in-Chief of the journal, Experimental Eye Research, published by Elsevier Science. He has edited twelve books, eleven on retinal degenerations and one on the structure of the eye.
Dr. Hollyfield has received the Marjorie W. Margolin Prize (1981, 1994), the Sam and Bertha Brochstein Award (1985) and the Award of Merit in Retina Research (1998) from the Retina Research Foundation; the Olga Keith Wiess Distinguished Scholars' Award (1981), two Senior Scientific Investigator Awards (1988, 1994) from Research to Prevent Blindness, Inc.; an award for Outstanding Contributions to Vision Research from the Alcon Research Institute (1987); the Distinguished Alumnus Award (1991) from Hendrix College, Conway, Ark.; and the Endre A. Balazs Prize (1994) from the International Society for Eye Research. Dr. Hollyfield has been active in the Association for Research in Vision and Ophthalmology serving on the Program Committee, as a Trustee and as President. He is also a Past President and former Secretary of the International Society of Eye Research.
He currently serves on the Scientific Advisory Boards of the Foundation Fighting Blindness, Research to Prevent Blindness, the Helen Keller Eye Research Foundation, the South Africa Retinitis Pigmentosa Foundation, Knights Templar Eye Foundation, and is Co-Chairman of the Medical and Scientific Advisory Board of Retina International.
Specialty Interests
macular degeneration, inherited retinal disease, basic biology and the outer retina
Industry Relationships
Cleveland Clinic physicians and scientists may collaborate
with the pharmaceutical or medical device industries
to help develop medical breakthroughs or provide
medical education about recent trends. The
collaborations are reviewed as part of the Cleveland
Clinic’s procedures. The Cleveland Clinic publicly
discloses payments to its physicians and scientists
for speaking and consulting of
$5,000 or more per year, and any equity, royalties,
and fiduciary relationships in companies with which
they collaborate. In publicly disclosing this
information, the Cleveland Clinic tries to provide
information as accurately as possible about its
doctors’ connections with industry and those of their
immediate family members. As of 10/7/2008, Dr.
Hollyfield has reported the financial relationships
with the companies listed below. Patients should feel
free to contact their doctor about any of the
relationships and how the relationships are overseen
by the Cleveland Clinic. To learn more about the
Cleveland Clinic’s policies on collaborations with
industry and innovation management, go to
our Integrity in Innovation page.
Consulting. Dr. Hollyfield receives fees of $5,000 or more per year as a paid consultant or speaker for the following companies:
- Elsevier Inc.
- Genentech, Inc.
Royalty Payments. Dr. Hollyfield has the right to receive royalty payments for inventions or discoveries related to the companies shown below:
- Alcon Laboratories
- Frantz Biomarkers, LLC
- Genentech, Inc.
- Lux Biosciences
